MiNK Therapeutics, Inc. Earnings Per Share (Basic)
MiNK Therapeutics, Inc. (INKT) reported Earnings Per Share (Basic) of -$0.62 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- MiNK Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.62.
- MiNK Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.57.
- MiNK Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.56.
- MiNK Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.65.
- MiNK Therapeutics, Inc. earnings per share, basic for fiscal 2025 was -$2.93.
- MiNK Therapeutics, Inc. earnings per share, basic for fiscal 2024 was -$2.86.
- MiNK Therapeutics, Inc. earnings per share, basic for fiscal 2023 was -$6.54.
- MiNK Therapeutics, Inc. earnings per share, basic for fiscal 2022 was -$0.83.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.62 10-Q · filed 2026-08-13 | -$1.20 10-Q · filed 2026-08-13 | -$1.75 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$2.40 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2026-03-31 | -$0.57 10-Q · filed 2026-05-15 | -$1.13 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$1.77 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$2.79 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-12-31 | -$0.56 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$1.20 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$2.23 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$2.93 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | -$0.65 10-Q · filed 2025-11-14 | -$1.69 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$2.39 10-Q · filed 2025-11-14 | -$3.02 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-06-30 | -$1.06 10-Q · filed 2026-08-13 | -$1.76 10-Q · filed 2026-08-13 | -$2.39 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$2.84 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-03-31 | -$0.70 10-Q · filed 2026-05-15 | -$1.32 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$1.78 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$2.50 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2024-12-31 | -$0.62 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$1.08 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$1.80 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$2.86 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | -$0.46 10-Q · filed 2025-11-14 | -$0.05 10-Q · filed 2024-11-14 | -$1.18 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$2.24 10-Q · filed 2025-11-14 | -$0.22 10-Q · filed 2024-11-14 | $0.71 derived: net income ÷ weighted average shares · filed 2025-11-14 | ||
| 2024-06-30 | -$0.73 10-Q · filed 2025-08-14 | -$0.07 10-Q · filed 2024-08-13 | -$1.82 10-Q · filed 2025-08-14 | -$0.18 10-Q · filed 2024-08-13 | $0.44 derived: net income ÷ weighted average shares · filed 2025-11-14 | $1.44 derived: net income ÷ weighted average shares · filed 2025-11-14 | ||
| 2024-03-31 | -$1.10 10-Q · filed 2025-05-15 | -$0.11 10-Q · filed 2024-05-14 | $0.22 derived: net income ÷ weighted average shares · filed 2025-11-14 | $0.84 derived: net income ÷ weighted average shares · filed 2025-11-14 | $4.91 derived: net income ÷ weighted average shares · filed 2025-11-14 | |||
| 2023-12-31 | $0.06 derived: net income ÷ weighted average shares · filed 2025-03-18 | $0.39 derived: net income ÷ weighted average shares · filed 2025-03-18 | $2.49 derived: net income ÷ weighted average shares · filed 2025-03-18 | -$6.54 10-K · filed 2025-03-18 | -$0.65 10-K · filed 2024-03-21 | |||
| 2023-09-30 | -$0.15 10-Q · filed 2024-11-14 | -$0.33 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$0.50 10-Q · filed 2024-11-14 | -$0.72 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||||
| 2023-06-30 | -$0.18 10-Q · filed 2024-08-13 | -$0.35 10-Q · filed 2024-08-13 | -$0.58 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$0.76 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||||
| 2023-03-31 | -$0.17 10-Q · filed 2024-05-14 | -$0.40 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$0.58 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$0.77 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||||
| 2022-12-31 | -$0.23 derived: net income ÷ weighted average shares · filed 2024-03-21 | -$0.42 derived: net income ÷ weighted average shares · filed 2024-03-21 | -$0.60 derived: net income ÷ weighted average shares · filed 2024-03-21 | -$0.83 10-K · filed 2024-03-21 | ||||
| 2022-09-30 | -$0.19 10-Q · filed 2023-11-14 | -$0.37 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$0.60 10-Q · filed 2023-11-14 | -$0.78 derived: net income ÷ weighted average shares · filed 2023-11-14 | ||||
| 2022-06-30 | -$0.18 10-Q · filed 2023-08-10 | -$0.41 10-Q · filed 2023-08-10 | -$0.60 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$1.10 derived: net income ÷ weighted average shares · filed 2023-11-14 | ||||
| 2022-03-31 | -$0.23 10-Q · filed 2023-05-11 | -$0.42 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$0.93 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$1.20 derived: net income ÷ weighted average shares · filed 2023-11-14 | ||||
| 2021-12-31 | -$0.18 derived: net income ÷ weighted average shares · filed 2023-03-24 | -$0.72 derived: net income ÷ weighted average shares · filed 2023-03-24 | -$0.99 derived: net income ÷ weighted average shares · filed 2023-03-24 | -$1.16 10-K · filed 2023-03-24 | ||||
| 2021-09-30 | -$0.59 10-Q · filed 2022-11-03 | -$0.85 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$1.01 10-Q · filed 2022-11-03 | |||||
| 2021-06-30 | -$0.26 10-Q · filed 2022-08-15 | -$0.42 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |